APT Medical Inc. (SHA:688617)
China
· Delayed Price · Currency is CNY 394.08
+2.08 (0.53%)
Jun 6, 2025, 2:45 PM CST
APT Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Net Income | - | 658.17 | 533.92 | 358.02 | 207.92 | 110.78 | Upgrade
|
| Depreciation & Amortization | - | 87.44 | 64.01 | 48.26 | 33.44 | 20 | Upgrade
|
| Other Amortization | - | 3.6 | 3.88 | 3.22 | 1.11 | 0.74 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.25 | -10.81 | -0.06 | -0.02 | -0 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 25.46 | 3.97 | 10.68 | 3.57 | 0.24 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -13.17 | -23.13 | -21.09 | -32.82 | 0.07 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -0.18 | 0.79 | -0.51 | 0.28 | Upgrade
|
| Other Operating Activities | - | 9.58 | 0.91 | -13.45 | -3.88 | -5.13 | Upgrade
|
| Change in Accounts Receivable | - | -74.73 | 20 | -23.17 | 4.3 | 25.33 | Upgrade
|
| Change in Inventory | - | -79.29 | 11.22 | -72.59 | -124.21 | -2.44 | Upgrade
|
| Change in Accounts Payable | - | 134.47 | 68.9 | 61.71 | 82.51 | -0.48 | Upgrade
|
| Change in Other Net Operating Assets | - | 7.24 | 21.28 | 14.19 | 18.17 | -0.85 | Upgrade
|
| Operating Cash Flow | - | 743.39 | 689.06 | 367.46 | 181.39 | 148.24 | Upgrade
|
| Operating Cash Flow Growth | - | 7.89% | 87.52% | 102.58% | 22.36% | 170.03% | Upgrade
|
| Capital Expenditures | - | -650.24 | -202.03 | -143.21 | -167.38 | -44.2 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.6 | 12.67 | 0.23 | 0.04 | 0.01 | Upgrade
|
| Cash Acquisitions | - | - | -46.37 | - | - | - | Upgrade
|
| Investment in Securities | - | 22.79 | 797.82 | -39.16 | -947.7 | -30 | Upgrade
|
| Other Investing Activities | - | 9.06 | 19.82 | 47.61 | 4.93 | 74.92 | Upgrade
|
| Investing Cash Flow | - | -617.79 | 581.9 | -134.53 | -1,110 | 0.73 | Upgrade
|
| Long-Term Debt Issued | - | - | 70 | 82.6 | 23.5 | 16.41 | Upgrade
|
| Long-Term Debt Repaid | - | -71.18 | -49.62 | -84.16 | -35.72 | -115.19 | Upgrade
|
| Net Debt Issued (Repaid) | - | -71.18 | 20.38 | -1.56 | -12.22 | -98.78 | Upgrade
|
| Issuance of Common Stock | - | 78.53 | 34.67 | - | 1,199 | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | -59.99 | - | - | Upgrade
|
| Common Dividends Paid | - | -133.97 | -112.22 | -69.01 | -33.19 | -1.41 | Upgrade
|
| Other Financing Activities | - | -181.28 | -189.18 | -164.04 | -34.54 | -1.43 | Upgrade
|
| Financing Cash Flow | - | -307.9 | -246.36 | -294.6 | 1,119 | -101.62 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -13 | 2.84 | 0.96 | -1.02 | -0.53 | Upgrade
|
| Net Cash Flow | - | -195.3 | 1,027 | -60.71 | 189.32 | 46.83 | Upgrade
|
| Free Cash Flow | - | 93.15 | 487.03 | 224.25 | 14.01 | 104.04 | Upgrade
|
| Free Cash Flow Growth | - | -80.88% | 117.18% | 1500.56% | -86.53% | - | Upgrade
|
| Free Cash Flow Margin | - | 4.51% | 29.51% | 18.44% | 1.69% | 21.70% | Upgrade
|
| Free Cash Flow Per Share | - | 0.96 | 4.98 | 2.29 | 0.15 | 1.44 | Upgrade
|
| Cash Income Tax Paid | - | 250.68 | 203.93 | 146.02 | 78.34 | 52.64 | Upgrade
|
| Levered Free Cash Flow | - | -310.56 | 354.02 | 263.62 | -35.72 | 39.73 | Upgrade
|
| Unlevered Free Cash Flow | - | -310.56 | 356.32 | 264.53 | -34.7 | 40.25 | Upgrade
|
| Change in Net Working Capital | 228.13 | 223.26 | -144.1 | -107.99 | 28.87 | 2.85 | Upgrade
|
Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.